Navigation Links
Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
Date:9/5/2007

looking statements, which speak only as of the date on which they are made.

The Company's actual future results and trends may differ materially depending on a variety of factors discussed in the Company's filings with the Securities and Exchange Commission. Factors that may affect the Company's plans or results include without limitation: (a) the ability and willingness of the Company's operators, tenants, borrowers, managers and other third parties, as applicable, to meet and/or perform the obligations under their various contractual arrangements with the Company; (b) the ability and willingness of Kindred Healthcare, Inc. (together with its subsidiaries, "Kindred"), Brookdale Living Communities, Inc. (together with its subsidiaries, "Brookdale") and Alterra Healthcare Corporation (together with its subsidiaries, "Alterra") to meet and/or perform their obligations to indemnify, defend and hold the Company harmless from and against various claims, litigation and liabilities under the Company's respective contractual arrangements with Kindred, Brookdale and Alterra; (c) the ability of the Company's operators, tenants, borrowers and managers, as applicable, to maintain the financial strength and liquidity necessary to satisfy their respective obligations and liabilities to third parties, including without limitation obligations under their existing credit facilities; (d) the Company's success in implementing its business strategy and the Company's ability to identify, underwrite, finance, consummate and integrate diversifying acquisitions or investments, including those in different asset types and outside the United States; (e) the nature and extent of future competition; (f) the extent of future or pending healthcare reform and regulation, including cost containment measures and changes in reimbursement policies, procedures and rates; (g) increases in the Company's cost of borrowing; (h) the ability of the Company's operators and managers, as applicable, to d
'/>"/>

SOURCE Ventas, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. WHO Declares Vietnam First Country to Control SARS
2. Prime Minister Declares War on AIDS
3. WHO declares Tuberculosis – ‘An Emergency’ in Afrca
4. Iranian Government Declares Holiday Due To Pollution
5. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
6. Fao Declares Humans Spread Avian Influenza Virus
7. Myanmar Declares Herself As A Country Free of Bird flu
8. Ramadoss Declares India Yaws Free
9. China Declares War on Unsafe Foods for Soldiers
10. Startling Expose – Physicians Often Have No Regular Source Of Health Car
11. Regular exercise prevents hip fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2
... child spikes a high fever, sometimes as high as 1... Shes rushed to the emergency room, the hospital r...ut no explanation is found. , Many families thou...nt respond to antibiotics or fever reducers like M...
...Magazine urges readers to participate in nationwid...IA, March 28 Smart Genetics has,announced that PA...art of a,nationwide poll asking readers if they wa...lligenc ,e_Report#health., PARADE, the nation,s m...
...ease in specific white blood cells could warn doct... March 28 (HealthDay News) -- Researchers at Templ...ker that denotes the progression of the virus that...s (HIV), according to a study published in the Mar...
...ASHINGTON, March 28 Richard T. Clark, Chief,Execu...oard chairman of the,Pharmaceutical Research and M... association,s annual meeting. Also elected were A...frey B.,Kindler as board treasurer., In addition,...
...lunt cerebrovascular injuries can be diagnosed usi...no need for an additional neck MDCT angiography ex... researchers at the University of Maryland Medical...In the past, blunt trauma patients would undergo w...
...hiladelphia, March 28, 2008 Many parents are conv...re different than those of children and adults. Ne...by Jay N. Giedd, MD, of the National Institute of ... cognition, emotion and behavior. , Dr. Giedd rev...
Other Medicine News:Health News:Mysterious fevers of unknown origin: Could surgery be a cure? 2Health News:PARADE Magazine Features Smart Genetics and Alzheimer's Mirror 2Health News:Biomarker May Signal HIV Progression 2Health News:Richard T. Clark Elected PhRMA Board Chairman 2Health News:Richard T. Clark Elected PhRMA Board Chairman 3Health News:Richard T. Clark Elected PhRMA Board Chairman 4Health News:Richard T. Clark Elected PhRMA Board Chairman 5Health News:Whole body MDCT just as 'good' as neck MDCT angiography in diagnosing head and neck injuries 2Health News:Are teenage brains really different? 2Health News:Are teenage brains really different? 3
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 1CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 2CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 3CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 4CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 5Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 1Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 2Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 3Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 4AUL President to Senate Judiciary Committee 3A Ask Top 10 Questions to Judge Sotomayor 51274 1AUL President to Senate Judiciary Committee 3A Ask Top 10 Questions to Judge Sotomayor 51274 2
Flammable Chemical Storage Cabinets
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q64-R-PAL
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q43-R-PAL
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q72-R-PAL
Medicine Products: